Avaxia Biologics Secures $2,872,388 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e24f87f-4d19-4638-885a-2c9bb3010a30
Date
12/23/2013
Company Name
Avaxia Biologics
Mailing Address
128 Spring Street Lexington, MA 02421
Company Description
Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract.
Website
http://www.avaxiabiologics.com
Transaction Type
Debt
Transaction Amount
$2,872,388
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed